<DOC>
	<DOCNO>NCT00741390</DOCNO>
	<brief_summary>The procurement blood SMBG , usually via finger stick , consider many patient painful portion diabetes therapy . This lead marketing small gauge lancet , lance device variable depth setting blood glucose sensor require less blood measurement . In study , two main outcome evaluate : The first , assessed Visit 1 , whether specific combination lancet lance device would yield sufficient blood volume allow valid assessment diabetic subject ' glucose level . The outcome , assess Visit 2 , level pain perceived subject lance specific combination lancet lance device . During Visit 2 , pain assessment do use Visual Analog Scale lancet/lancing device , low lance device set yield valid BG reading subject Visit 1 use . A third outcome measure , overall comfort lancing , also assess Visit 2 . A total 5 combination lancet lance device evaluate . These follow : - BD/33G = BD Lancet device/BD 33G lancet ( BGM measure OneTouch® UltraMini™ ( BGM ) OneTouch® Ultra® test strip ) - OTM/33G =OneTouch® Mini Lancet device / BD 33G lancet ( BGM measure OneTouch® UltraMini™ ( BGM ) OneTouch® Ultra® test strip ) - OTM/28G =OneTouch® Mini Lancet device / OneTouch® UltraSoft® 28G Lancet ( BGM measure OneTouch® UltraMini™ ( BGM ) OneTouch® Ultra® test strip ) - OTU/28G = OneTouch® UltraSoft® Lancet device/OneTouch® UltraSoft® 28G Lancet ( BGM measure OneTouch® UltraMini™ ( BGM ) OneTouch® Ultra® test strip ) - ACC/28G= Accu-Chek® Softclix Lancet device/Accu-Chek® Softclix 28G Lancet ( BGM measure Accu-Chek® Advantage BGM Accu-Chek® Comfort Curve test strip ) After enrollment qualification , subject assign one 4 intervention arm . The arm assignment determine 3 5 combination lancet lance device subject would evaluate Visit 1 ( volume adequacy ) 3 , 2 would evaluate Visit 2 ( pain lancing ) . The lancet/lancing device combination assign arm show Assigned Interventions Table .</brief_summary>
	<brief_title>Evaluation Blood Volume Perceived Pain During Fingerstick Monitoring Blood Glucose</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Must currently diagnose either Type I Type II diabetes mellitus . Must currently perform self monitor blood glucose Must 1870 year age ( inclusive ) . Must able read follow study instruction English . Pregnant ( self report ) History poor blood circulation . Any skin condition finger prevents blood sampling . History bleed disorder . Neuropathy condition affect sensation hand . Selfreported blood borne infection ( e.g. , HIV , hepatitis B C [ non A , non B ] , syphilis , malaria , babesiosis , brucellosis , leptospirosis , arboviral infection , relapse fever , T lymphotropic virus Type 1 , CreutzfeldtJakob disease ) . Currently participate another study Employed BD , J &amp; J , Roche Clinical Site .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Lancets</keyword>
	<keyword>Pain</keyword>
</DOC>